BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials
5/8/2026
-
MarketBeat
5/12/2026
-
Simply Wall St
5/11/2026
-
TipRanks Financial Blog
5/10/2026
-
TipRanks Financial Blog
5/9/2026
-
MarketBeat
5/9/2026
-
Seeking Alpha: Transcripts
5/9/2026
-
SeekingAlpha
5/8/2026
-
MarketBeat
5/8/2026
-
Seeking Alpha - Healthcare
5/8/2026
-
Globe Newswire
5/4/2026
-
Globe Newswire
4/27/2026
-
MarketBeat
4/25/2026
-
MarketBeat
4/24/2026
-
Seeking Alpha: Transcripts
4/24/2026
-
SeekingAlpha
4/24/2026
-
MarketBeat
4/23/2026
-
Zacks Investment Research
4/22/2026
-
MarketBeat
4/21/2026
-
PR Newswire
4/21/2026
-
TipRanks Financial Blog
4/21/2026
-
Zacks Investment Research
4/21/2026
-
TipRanks Financial Blog
4/21/2026
-
Globe Newswire
4/17/2026
-
MarketBeat
4/17/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 8, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 806 1445
Address
5885 Hollis Street
EmeryVille, CA 94608
EmeryVille, CA 94608
Country
Year Founded
Business Description
Sector
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets...
more